Stockwatch

NeutriSci International Inc
Symbol	NU
Shares Issued	178,424,267
Close 2023-03-15	C$ 0.015
Market Cap	C$ 2,676,364
Recent Sedar+ Documents

NeutriSci receives nod to sell neuenergy in Germany

2023-03-15 06:59 ET - News Release

Ackerman Subject: NeutriSci press release for dissemination Word Document File: '\\swfile\EmailIn\20230315 030145 Attachment NU Press Release_Germany apporoval and Trademark_March 15 2023 final.docx' NEUTRISCI RECEIVES EUROPEAN APPROVALS Approved Trademarks For neuenergy(TM) In Europe neuenergy(TM) Receives Approval From The Food Control Authority To Sell Product In Germany Vancouver, British Columbia - March 15, 2023 - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTC PINK: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce that it has received approval for the trademark neuenergy(TM) and it has also received approval from the Food Control Authority to sell neuenergy(TM) throughout Germany. With approvals in hand, the Company's European distribution partner, TH International Consulting GmbH ("THIC"), will begin the immediate ramp up of sales efforts for the neuenergy(TM) product. Founded in 2012 and based in Esslingen, Germany, THIC is successfully active in the areas of consulting, marketing, as well as direct marketing. THIC has the exclusivity to distribute and sell neuenergy(TM) in the European market, with an initial focus on the German-speaking countries. neuenergy(TM) is a sublingual energy tablet that boosts concentration and mental clarity without sugar, calories, and any subsequent crash, as is the case with many conventional energy products. neuenergy(TM) contains a unique and patented combination of ingredients that make the product so effective at giving the end user the type clarity, focus and energy needed to complete any task. THIC's market strategy has identified several promising target groups that will be incorporated into the THIC sales strategy. To assist in this endeavor, THIC has assembled a strong and experienced sales team dedicated to the European product launch of neuenergy(TM). Target markets will include online sales on www.getneuenergy.de and the Amazon platform which is available to consumers in Germany and several European countries, retail locations and a fitness network consisting of 150,000 members. Yusuf Taze, Managing Director of THIC, commented, "We are pleased to have finally received approvals from the German Food Control Authority as well as the Trademarks for Europe. Now that we have completed these details, everything is in place to move forward, We are excited to implement our sales strategies and generating sales in Germany and other parts of the European market. Consumer feedback has been extremely positive, and this gives us an extremely bullish outlook on the future of neuenergy(TM) in Germany and the rest of Europe." Glen Rehman, CEO of NeutriSci, said, "We have been waiting for the completion of these details for some time. Now that they are here, we look forward to supporting THIC in every way possible to help them successfully bring neuenergy(TM) to Germany and the rest of Europe." About NeutriSci International Inc. NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for its products offering co-branding as well as private label opportunities and contract manufacturing services. For more information, please visit: www.neutrisci.com. On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC. Glen Rehman CEO Tel: (403) 264-6320 investors@neutrisci.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure, or prevent any disease. PDF Document File: Attachment NU Press Release_Germany apporoval and Trademark_March 15 2023 final.pdf NEUTRISCI RECEIVES EUROPEAN APPROVALS dot Approved Trademarks For neuenergyTM In Europe dot neuenergyTM Receives Approval From The Food Control Authority To Sell Product In Germany Vancouver, British Columbia March 15, 2023 NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTC PINK: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce that it has received approval for the trademark neuenergyTM and it has also received approval from the Food Control Authority to sell neuenergyTM throughout Germany. With approvals in hand, the Company's European distribution partner, TH International Consulting GmbH ("THIC"), will begin the immediate ramp up of sales efforts for the neuenergyTM product. Founded in 2012 and based in Esslingen, Germany, THIC is successfully active in the areas of consulting, marketing, as well as direct marketing. THIC has the exclusivity to distribute and sell neuenergyTM in the European market, with an initial focus on the German-speaking countries. neuenergyTM is a sublingual energy tablet that boosts concentration and mental clarity without sugar, calories, and any subsequent crash, as is the case with many conventional energy products. neuenergyTM contains a unique and patented combination of ingredients that make the product so effective at giving the end user the type clarity, focus and energy needed to complete any task. THIC's market strategy has identified several promising target groups that will be incorporated into the THIC sales strategy. To assist in this endeavor, THIC has assembled a strong and experienced sales team dedicated to the European product launch of neuenergyTM. Target markets will include online sales on www.getneuenergy.de and the Amazon platform which is available to consumers in Germany and several European countries, retail locations and a fitness network consisting of 150,000 members. Yusuf Taze, Managing Director of THIC, commented, "We are pleased to have finally received approvals from the German Food Control Authority as well as the Trademarks for Europe. Now that we have completed these details, everything is in place to move forward, We are excited to implement our sales strategies and generating sales in Germany and other parts of the European market. Consumer feedback has been extremely positive, and this gives us an extremely bullish outlook on the future of neuenergyTM in Germany and the rest of Europe." Glen Rehman, CEO of NeutriSci, said, "We have been waiting for the completion of these details for some time. Now that they are here, we look forward to supporting THIC in every way possible to help them successfully bring neuenergyTM to Germany and the rest of Europe." About NeutriSci International Inc. NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for its products offering co-branding as well as private label opportunities and contract manufacturing services. For more information, please visit: www.neutrisci.com. On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC. Glen Rehman CEO Tel: (403) 264-6320 investors@neutrisci.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward- looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure, or prevent any disease.